Natriuretic peptide proANP (1–98), a biomarker of ALI/ARDS in burns

Add time:08/29/2019    Source:sciencedirect.com

SummaryIntroductionPlasma atrial natriuretic peptide levels (proANP (1–98)), a parameter of myocardial dysfunction, have been reported to be increased in critically ill patients with acute lung injury/acute respiratory distress syndrome (ALI/ARDS). The aim of the study was to examine if proANP is a biomarker of ALI/ARDS as assessed by the Sequential Organ Failure Assessment score (SOFA Lung ≥ 2) in burn patients, and how it compares to the corresponding values for age, total body surface area percent (TBSA%) and inhalation injury for mortality prediction.

We also recommend Trading Suppliers and Manufacturers of atrial natriuretic factor (1-98) (cas 114101-49-4). Pls Click Website Link as below: cas 114101-49-4 suppliers

Prev:Chapter 15 - Atrial Natriuretic Peptide, the Hypothalamic–Pituitary–Adrenal Axis, and Panic Attacks
Next:Chapter 26. Atrial Natriuretic Factor)